The mathematician of the Complutense University of Madrid, José-Vidal Ruiz Varela, argues that Europe must raise its borrowing limit, leaving its deflationary policy.
Cortesía de Investing.com

Agenda Macro

Calendario económico en tiempo real proporcionado por Investing.com España.

Merck reports second-quarter drop in profit, sales

NEW YORK (MarketWatch)
Merck & Co. Inc. reported its second-quarter profit fell to $906 million, or 30 cents a share, from $1.79 billion, or 58 cents a share, a year earlier
Adjusted to exclude acquisition and restructuring costs, the company reported profit of $2.53 billion, or 84 cents a share, down from $3.23 billion, or $1.05 a share, a year ago
Revenue fell to $11.01 billion, from $12.31 billion a year earlier, the pharmaceuticals company said
Analysts had expected earnings of 82 cents a share on revenue of $11.24 billion, according to FactSet
Sales of Singulair, the company's asthma and allergy drug, were down 80%, Merck said
The company reiterated its full-year 2013 earnings-per-share target of $1.84 to $2.05, and its adjusted target of $3.45 to $3.55

No hay comentarios: